🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 23 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/03/2004 | 43,01 | 43,22 | 42,88 | 43,08 | +0,36% | 0,78% | 6.929.586 |
| 11/03/2004 | 43,65 | 44,80 | 42,76 | 42,93 | -2,51% | 4,68% | 9.375.513 |
| 10/03/2004 | 44,87 | 44,98 | 43,94 | 44,04 | -2,39% | 2,32% | 9.885.050 |
| 09/03/2004 | 45,28 | 45,41 | 44,99 | 45,11 | -0,82% | 0,93% | 6.222.814 |
| 08/03/2004 | 46,04 | 46,04 | 45,47 | 45,49 | -0,89% | 1,24% | 4.883.366 |
| 05/03/2004 | 45,28 | 46,07 | 45,17 | 45,90 | +0,67% | 1,98% | 6.340.610 |
| 04/03/2004 | 45,53 | 45,90 | 45,45 | 45,59 | +1,42% | 0,98% | 6.640.338 |
| 03/03/2004 | 45,13 | 45,23 | 44,67 | 44,95 | -1,34% | 1,25% | 7.498.964 |
| 02/03/2004 | 46,20 | 46,21 | 45,32 | 45,56 | -1,44% | 1,92% | 10.426.028 |
| 01/03/2004 | 46,20 | 46,37 | 45,85 | 46,23 | +0,77% | 1,14% | 5.237.904 |
| 27/02/2004 | 45,82 | 46,40 | 45,65 | 45,88 | +0,92% | 1,65% | 7.618.750 |
| 26/02/2004 | 45,28 | 45,62 | 45,26 | 45,46 | -0,52% | 0,80% | 7.477.794 |
| 25/02/2004 | 46,28 | 46,43 | 45,50 | 45,70 | -1,26% | 2,02% | 8.946.252 |
| 24/02/2004 | 46,32 | 46,39 | 46,03 | 46,28 | -0,08% | 0,78% | 5.724.805 |
| 23/02/2004 | 46,25 | 46,56 | 46,11 | 46,32 | +0,48% | 0,99% | 5.457.984 |
| 20/02/2004 | 46,71 | 46,72 | 45,93 | 46,10 | -1,13% | 1,70% | 6.375.822 |
| 19/02/2004 | 46,83 | 46,91 | 46,56 | 46,62 | -0,45% | 0,75% | 8.557.654 |
| 18/02/2004 | 46,71 | 46,94 | 46,69 | 46,83 | +0,45% | 0,53% | 8.936.401 |
| 17/02/2004 | 46,58 | 46,76 | 46,36 | 46,62 | -0,04% | 0,86% | 5.649.454 |
| 13/02/2004 | 46,11 | 46,81 | 46,10 | 46,64 | +1,18% | 1,55% | 6.772.595 |
| 12/02/2004 | 46,39 | 46,70 | 45,95 | 46,10 | -0,64% | 1,60% | 5.266.934 |
| 11/02/2004 | 46,15 | 46,52 | 45,83 | 46,39 | +0,45% | 1,49% | 5.879.280 |
| 10/02/2004 | 46,04 | 46,23 | 45,99 | 46,18 | +0,48% | 0,52% | 6.030.821 |
| 09/02/2004 | 46,47 | 46,56 | 45,84 | 45,96 | -1,21% | 1,56% | 5.779.930 |
| 06/02/2004 | 46,51 | 46,80 | 46,16 | 46,53 | +0,04% | 1,37% | 6.120.739 |
| 05/02/2004 | 46,75 | 47,07 | 46,26 | 46,51 | -0,41% | 1,74% | 8.924.873 |
| 04/02/2004 | 46,37 | 46,95 | 46,28 | 46,70 | +0,91% | 1,44% | 11.642.337 |
| 03/02/2004 | 45,82 | 46,28 | 45,62 | 46,28 | +0,89% | 1,44% | 7.594.751 |
| 02/02/2004 | 45,69 | 46,00 | 45,19 | 45,87 | +0,99% | 1,78% | 8.026.737 |
| 30/01/2004 | 45,88 | 45,96 | 45,13 | 45,42 | -1,41% | 1,81% | 8.639.293 |